Skin Infection News and Research

RSS
Actavis reports positive results from phase 3 study of single-dose DALVANCE for treatment of ABSSSI

Actavis reports positive results from phase 3 study of single-dose DALVANCE for treatment of ABSSSI

TSRI scientists uncover unique mechanism of natural product with antimicrobial, anti-cancer effects

TSRI scientists uncover unique mechanism of natural product with antimicrobial, anti-cancer effects

New study sheds light on natural small molecule with antimicrobial effects

New study sheds light on natural small molecule with antimicrobial effects

Two common antibiotic treatments equally effective against MRSA skin infections

Two common antibiotic treatments equally effective against MRSA skin infections

Study shows that households can serve as reservoir for transmitting MRSA

Study shows that households can serve as reservoir for transmitting MRSA

Salt may help control infection

Salt may help control infection

Synthetic compound shows antibiotic action against MRSA

Synthetic compound shows antibiotic action against MRSA

Debiopharm receives FDA Fast Track designation for anti-infectious agent Debio 1450

Debiopharm receives FDA Fast Track designation for anti-infectious agent Debio 1450

Fat cells below skin help protect from bacteria, say researchers

Fat cells below skin help protect from bacteria, say researchers

Study: Using wash cloths treated with skin cleanser could reduce skin infections in U.S. jails

Study: Using wash cloths treated with skin cleanser could reduce skin infections in U.S. jails

NPS MedicineWise calls all Australians to join the fight against antibiotic resistance

NPS MedicineWise calls all Australians to join the fight against antibiotic resistance

Nearly half of hog workers carry livestock-associated bacteria to home

Nearly half of hog workers carry livestock-associated bacteria to home

Wockhardt receives coveted QIDP status from FDA for WCK 771 and WCK 2349 drugs

Wockhardt receives coveted QIDP status from FDA for WCK 771 and WCK 2349 drugs

Researchers report that predominant CA-MRSA strain migrated from sub-Saharan Africa

Researchers report that predominant CA-MRSA strain migrated from sub-Saharan Africa

New nanosheets can cling to body's most difficult-to-protect contours and keep bacteria at bay

New nanosheets can cling to body's most difficult-to-protect contours and keep bacteria at bay

Dermatologist warns about safety of children's skin care products

Dermatologist warns about safety of children's skin care products

Cubist Pharmaceuticals' SIVEXTRO receives FDA approval for treatment of ABSSSI

Cubist Pharmaceuticals' SIVEXTRO receives FDA approval for treatment of ABSSSI

Ferrer recruits first patient in second phase III trial of Ozenoxacin for treatment of impetigo

Ferrer recruits first patient in second phase III trial of Ozenoxacin for treatment of impetigo

Cubist Pharmaceuticals publishes positive results from Phase 3 clinical trial of SIVEXTRO

Cubist Pharmaceuticals publishes positive results from Phase 3 clinical trial of SIVEXTRO

New single-dose antibiotic is as effective as twice-daily infusion given for up to 10 days

New single-dose antibiotic is as effective as twice-daily infusion given for up to 10 days